About
Perry C. Siatis is Executive Vice President, General Counsel and Secretary, responsible for the global legal organization, the office of ethics and compliance, and government affairs. He began his career practicing commercial and intellectual property litigation at DLA Piper LLP and joined Abbott in 2005 as Counsel, later serving as Division Counsel, IP Litigation and as Divisional Vice President and Section Head, IP Strategy.
He joined AbbVie in January 2013 as Vice President, Biologic Strategic Development and Legal Regulatory, and led the legal strategy for AbbVie's 2020 acquisition of Allergan.
Roles
AbbVie Inc.
Executive Vice President, General Counsel and Secretary · Current role
Oct 2022–present
AbbVie
Senior Vice President, Deputy General Counsel
Sep 2021 - Oct 2022
AbbVie
Senior Vice President, Legal and Chief Ethics and Compliance Officer
2013 - 2021
Abbott
Joined · Joined Abbott in 2005
—
DLA Piper LLP
Commercial and IP litigation attorney · Began his career here
—
Abbott
Counsel; Division Counsel, IP Litigation; Divisional Vice President, IP Strategy · Joined Abbott in 2005
—
Also at AbbVie Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.